Mark Wechsler, MD
Anesthesiology · Weymouth, MANPI 1245407378
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Braeburn Inc. at 54.9% of the total. 2025 is the largest year on record at $2,987, more than ten times the $195 reported in 2019. Among anesthesiology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $63.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Braeburn Inc.$3K
- Relievant Medsystems, Inc.$612
- Boston Scientific$421
- Abbott$227
- Medtronic$206
- Vertos Medical, Inc.$182
- plus $736 from 15 others
What the payments were for
- Speaking & faculty fees$1,80034%
- Travel & lodging$1,01619%
- Food & beverage$2,46547%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Braeburn Inc. | 11 | $2,897 |
| Relievant Medsystems, Inc. | 8 | $612 |
| Boston Scientific | 16 | $421 |
| Abbott | 9 | $227 |
| Medtronic(2 entities) | 4 | $206 |
| Vertos Medical, Inc. | 5 | $182 |
| AbbVie | 6 | $149 |
| Zimmer Biomet | 3 | $121 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $77 |
| Nevro Corp. | 3 | $69 |
| Stryker | 1 | $50 |
| Biotronik NRO, Inc. | 1 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Pfizer | 2 | $31 |
| Bioventus LLC | 1 | $28 |
| Amgen | 1 | $24 |
| Saluda Medical Americas, Inc. | 1 | $24 |
| Baudax Bio Inc. | 1 | $23 |
| Si-bone, Inc. | 2 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Avanos Medical | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BRIXADI$2,582
- Intracept$1,562
- mild Device Kit$101
How this compares
$5,281 in reported general payments places this provider in the 90th percentile of 1,585 anesthesiology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 17 | $643 |
| Cyclobenzaprine Hcl | 42 | $503 |
| Tizanidine Hcl | 13 | $325 |
| Etodolac | 19 | $283 |
| Pregabalin | 17 | $171 |
| Gabapentin | 15 | $107 |
| Methylprednisolone | 14 | $79 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Weymouth
- James StreisandCambridge$380K
- Douglas ShookBoston$267K
- Paula BokeschLexington$244K
- Robert YongBoston$231K
- Michael DambraBoston$194K
- Jasmine PatelWorcester$180K
- Robert TruogBoston$172K
- Mary Ellen McCannBoston$140K
- Stanton ShernanBoston$136K
- Edgar RossBoston$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.